ArticleBritish journal of clinical pharmacology2021

A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator.

Jonas M den Heijer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.